Statistics for Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
Total visits
| views | |
|---|---|
| Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024 | 12 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 2 |
| October 2025 | 0 |
| November 2025 | 2 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| IRV-18-e70009.pdf | 14 |
| null | 3 |
Top country views
| views | |
|---|---|
| Portugal | 10 |
| Italy | 1 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Braga | 9 |
| Atlanta | 1 |
| Lisbon | 1 |
| Milan | 1 |